Patents by Inventor PHILIPP HASELMAYER

PHILIPP HASELMAYER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180179231
    Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
    Type: Application
    Filed: October 1, 2015
    Publication date: June 28, 2018
    Inventors: MARKUS KLEIN, OLIVER SCHADT, PHILIPP HASELMAYER, MICHAEL BUSCH
  • Publication number: 20180179232
    Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
    Type: Application
    Filed: October 1, 2015
    Publication date: June 28, 2018
    Inventors: MARKUS KLEIN, OLIVER SCHADT, PHILIPP HASELMAYER, MIREILLE KRIER
  • Publication number: 20180105538
    Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 19, 2018
    Inventors: MARKUS KLEIN, OLIVER SCHADT, PHILIPP HASELMAYER, MICHAEL BUSCH
  • Publication number: 20180105539
    Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 19, 2018
    Inventors: MARKUS KLEIN, OLIVER SCHADT, PHILIPP HASELMAYER, MICHAEL BUSCH